These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34799745)

  • 21. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.
    McCarty TR; Itidiare M; Njei B; Rustagi T
    Endoscopy; 2018 Jul; 50(7):708-725. PubMed ID: 29625507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes.
    Testoni PA; Mazzoleni G; Testoni SG
    World J Gastrointest Pharmacol Ther; 2016 May; 7(2):179-89. PubMed ID: 27158533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.
    Chimukangara M; Jalilvand AD; Melvin WS; Perry KA
    Surg Endosc; 2019 Apr; 33(4):1304-1309. PubMed ID: 30167944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective.
    Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG
    Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms.
    Trad KS; Turgeon DG; Deljkich E
    Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transoral Incisionless Fundoplication (TIF 2.0): A Meta-Analysis of Three Randomized, Controlled Clinical Trials.
    Gerson L; Stouch B; Lobonţiu A
    Chirurgia (Bucur); 2018; 113(2):173-184. PubMed ID: 29733015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of EsophyX2.0 and MUSE systems for transoral incisionless fundoplication: Technical aspects and outcomes up to 3 years.
    Testoni SGG; Pantaleo G; Contu F; Azzolini F; Fanti L; Testoni PA
    Dig Endosc; 2024 May; ():. PubMed ID: 38818692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
    Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
    Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transoral incisionless fundoplication with or without hiatal hernia repair for gastroesophageal reflux disease after peroral endoscopic myotomy.
    DeWitt JM; Al-Haddad M; Stainko S; Perkins A; Fatima H; Ceppa DP; Birdas TJ
    Endosc Int Open; 2024 Jan; 12(1):E43-E49. PubMed ID: 38188922
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature.
    Wendling MR; Melvin WS; Perry KA
    Surg Endosc; 2013 Oct; 27(10):3754-61. PubMed ID: 23644835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication.
    Huynh P; Konda V; Sanguansataya S; Ward MA; Leeds SG
    Surg Laparosc Endosc Percutan Tech; 2020 Dec; 31(2):264-276. PubMed ID: 33347088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis.
    Haseeb M; Brown JRG; Hayat U; Bay C; Bain PA; Jirapinyo P; Thompson CC
    Gastrointest Endosc; 2023 Mar; 97(3):394-406.e2. PubMed ID: 36402203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current aspects of surgical treatment of gastro-esophageal reflux disease].
    Danilova DA; Bazaev AV; Gorbunova LI
    Khirurgiia (Mosk); 2020; (2):89-94. PubMed ID: 32105262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
    Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
    World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoscopic Treatments of GERD.
    Rouphael C; Padival R; Sanaka MR; Thota PN
    Curr Treat Options Gastroenterol; 2018 Mar; 16(1):58-71. PubMed ID: 29340935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.
    Witteman BP; Strijkers R; de Vries E; Toemen L; Conchillo JM; Hameeteman W; Dagnelie PC; Koek GH; Bouvy ND
    Surg Endosc; 2012 Nov; 26(11):3307-15. PubMed ID: 22648098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Benefits of Nonablative Radiofrequency Treatment of the Lower Esophageal Sphincter After Transoral Incisionless Fundoplication.
    Fanous M; Jaehne A; Simbob J
    Am Surg; 2020 Nov; 86(11):1525-1527. PubMed ID: 32683926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is patient satisfaction sufficient to validate endoscopic anti-reflux treatments?
    Bortolotti M
    World J Gastroenterol; 2022 Jul; 28(28):3743-3746. PubMed ID: 36161053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transoral incisionless fundoplication demonstrates durability at up to 9 years.
    Bell RCW; Freeman K; Heidrick R; Ayazi S
    Therap Adv Gastroenterol; 2021; 14():17562848211004827. PubMed ID: 33948113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.